Delivery Order SPE2D020D0009-SPE2D325F0806

Award Date 10/23/24
Potential Completion Date 10/28/24
Potential Value $3.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $78,482.57, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of 4,561,244,124 vials of vancomycin, a critical antibiotic medication, with a performance period ending on June 6, 2023. This contract is not set aside for any specific business type. Fresenius Kabi, LLC is a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The $12,220.60 firm fixed-price delivery order is for the supply of 1 gram vials of the antibiotic drug vancomycin, with an ultimate completion date of October 28, 2024. Fresenius Kabi is a major supplier of critical care pharmaceuticals, including injectable medications, infusion...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract, valued at $9,692.20, is a delivery order for the supply of 4,566,185,312 units of Vancomycin 1 gram vials. The contract has an ultimate completion date of October 28, 2024, and is a firm fixed-price contract. Fresenius Kabi, LLC is a significant supplier of critical care...
This federal contract award is a delivery order (SPE2D020D0009|SPE2D325F0869) from the Defense Logistics Agency (DLA) Troop Support Medical division, a defense agency, to Fresenius Kabi, LLC, a foreign-owned pharmaceutical company based in Lake Zurich, Illinois. The $369,567.80 firm-fixed-price contract is for the delivery of 4,566,196,941 units of the antibiotic drug vancomycin in 1 gram vials. The contract has an ultimate completion date of October 29, 2024 and does not have a set-aside...
This federal contract award, valued at $39,653.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 4,566,185,310 vials of the antibiotic drug vancomycin 1 gram, which is a critical medical treatment for military and federal healthcare facilities. The contract has an ultimate completion date of October 28, 2024, and is structured as a firm fixed-price...
This is a delivery order contract awarded to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, valued at $42,434.98, is for the delivery of Vancomycin 1 gram vials to federal government agencies. The contract is a firm fixed-price delivery order with an ultimate completion date of October 28, 2024. Fresenius Kabi is a significant supplier of critical care pharmaceuticals, focusing primarily...
This is a firm-fixed-price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule contract, awarded by the Defense Logistics Agency Troop Support Medical to Fresenius Kabi USA, LLC, a foreign-owned, for-profit pharmaceutical company. The contract is for the delivery of 10 packages of 1 gram vials of vancomycin hydrochloride, a critical antibiotic medication. The award has a ceiling value of $204,603.28 and a period of performance ending on March 31, 2016. This contract does...
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, to Fresenius Kabi USA, LLC, a foreign-owned pharmaceutical company. The contract is for the delivery of 10 packages of 1 gram vials of vancomycin hydrochloride, an antibiotic medication, at a firm-fixed price of $97,711.52. The contract does not have a set-aside designation, indicating it was a full and open competition. This award was likely made against the...
This is a definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to Fresenius Kabi, LLC, a foreign-owned for-profit pharmaceutical company. The contract, valued at $41,636,277.00, is for the delivery of pharmaceutical and medical supplies, with no set-aside designation. The contract is structured as a firm fixed-price, delivery order arrangement to support medical facilities worldwide, particularly for the Department of Defense...
This federal contract award is for the delivery of Doxycycline Hydrochloride Injection (10) to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The prime contractor is Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is a delivery order with a firm fixed price of $22,035.23 and a completion date of September 27, 2024. There is no set-aside designation associated with this contract. Fresenius Kabi, LLC...
  • SPE2D020D0009
    Indefinite Delivery Contract
  • SPE2D020D0009-SPE2D325F0806
    Delivery Order

This federal contract award, valued at $3,202.64, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Fresenius Kabi, LLC, a foreign-owned, for-profit pharmaceutical company based in Lake Zurich, Illinois. The contract is for the delivery of 1 gram vials of the antibiotic Vancomycin, which is a critical care pharmaceutical used in military and federal healthcare facilities.

The contract does not have a set-aside designation and is structured as a firm-fixed-price delivery order with an ultimate completion date of October 28, 2024. Fresenius Kabi, LLC, which is a child entity of a larger corporate structure, has established itself as a key vendor in the federal medical supply chain, particularly for the Department of Defense and Department of Veterans Affairs. The company holds a significant indefinite delivery contract (IDV) with the Department of Veterans Affairs National Acquisition Center for the supply of bortezomib, a cancer treatment drug, further demonstrating its capability to secure and manage large-scale pharmaceutical supply contracts for critical medical treatments across various federal healthcare systems.

Generated 1/22/25, 9:12 AM